m+Medelevator.RU
← Поиск публикаций
Cureus · 2025

Knowledge, Attitudes and Practices of Japanese Cardiovascular Surgeons on the Management of Surgical Site Complications and Prophylactic Single-Use Negative Pressure Wound Therapy After Coronary Artery Bypass Surgery: A Quantitative Survey.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Takagi Kazuyoshi, Wee Yan Ran, Fujita Natsumi, Ng Alvin, Francis-Graham Seth, Seno Akie

Аннотация

Objective This study assessed the knowledge, attitudes and practices of cardiovascular surgeons in Japan on prophylactic single-use negative pressure wound therapy (sNPWT) after coronary artery bypass grafting (CABG). Methods A survey was distributed online to an anonymous Japanese market research panel in April 2024 (target: 50 responses). Eligible respondents were cardiovascular surgeons practising in Japan, with five or more years of experience and having performed 20 or more CABG surgeries in the past year. Responses were analysed descriptively. Results Among the 50 respondents (38% general, 30% national/public, 24% university hospitals), most agreed that the consequences of surgical site complications (SSCs) following cardiovascular surgery were more severe than other surgeries (78%), that SSC prevention is a priority after CABG (80%), and that postoperative procedures are important for managing SSC risk (84%). However, sNPWT was rarely used routinely (2%). Only 24% reported prophylactic sNPWT use; 44% used sNPWT only upon signs of SSCs. Cost-related factors were important to 60‒70% of respondents in determining SSC prevention. There was low knowledge of approved indications and reimbursement criteria for sNPWT. While 52% would recommend prophylactic sNPWT, limited reimbursement (80%) and insufficient familiarity with safety (52%) and effectiveness (50%) data were reasons for non-use. Sixty percent of respondents agreed that Japan-specific sNPWT guidelines are needed. Conclusions Barriers to using prophylactic sNPWT in Japan include complex and limited reimbursement criteria, cost concerns, insufficient local evidence and low awareness of existing evidence. Addressing these challenges may encourage prophylactic sNPWT use, leading to reduced postoperative complications, lower healthcare costs, and minimised disparities in care.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты